Abstract:Background The APOE4 gene is a strong risk factor for Alzheimer’s disease (AD). However, an understanding of the APOE4 genotype‐associated cellular and molecular processes in the brains remains unclear. Method To clarify the APOE4‐related pathogenic pathways in AD, we performed single‐nuclei RNA‐sequencing and spatial enhanced resolution omics sequencing on the brains of aging human APOE3‐knockin mice and APOE4 knock‐in mice. We also investigated the relationship between different cell types and AD‐related pathology in APOE knock‐in mice using immunostaining. We conducted amplification‐based single molecule in situ hybridization to validate the characteristics of the APOE4‐specific subcluster. To substantiate the APOE knock‐in mice analyses, we also re‐analyzed a published single‐nuclei RNA‐seq dataset containing postmortem prefrontal cortex tissue samples from patients with AD and controls. Result We identified seven distinct cell types in brains from APOE‐knockin mice, and observed oligodendrocytes with most unique differentially expressed genes (Figure 1). And we found significantly increased Alzheimer’s disease‐related pathologies (including intracellular beta‐amyloid and phosphorylated tau) in oligodendrocytes in the hippocampus of APOE4‐KI mice compared to APOE3‐KI mice. Furthermore, an APOE4‐specific oligodendrocyte subcluster was identified. This subcluster had a dysregulated autophagy flux signature, which may affect neuronal oxidative stress and synaptic function (Figure 2). Both excitatory and inhibitory neurons presented dysregulation of genes related to synapse plasticity. Additionally, the oligodendrocyte subcluster significantly correlated with neuronal loss, beta‐amyloid deposition and tau phosphorylation in the brain tissues examined. We also found a similar oligodendrocyte subcluster in post‐mortem brains from AD patients. Conclusion Altogether, this study suggests the specific oligodendrocyte subcluster is related to the susceptibility of APOE4 to AD, and targeting autophagy changes in oligodendrocyte may be a novel therapeutic intervention approach in APOE4 carriers.

APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer’s disease with Lewy body pathology

Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis

APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids

Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids

Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer's disease

Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer’s Disease Spectrum

Cell-autonomous Effects of APOE4 in Restricting Microglial Response in Brain Homeostasis and Alzheimer’s Disease

Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer's disease

APOE4 Impairs Microglia ‐ Astrocyte Crosstalk in Alzheimer Disease

APOE4 impairs the microglial response in Alzheimer's disease by inducing TGF-mediated checkpoints

Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer's disease

APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFβ-mediated checkpoints

The Contributions of the Endolysosomal Compartment and Autophagy to APOE ɛ4 Allele-Mediated Increase in Alzheimer's Disease Risk

The Contributions of the Endolysosomal Compartment and Autophagy to APOEɛ4 Allele-Mediated Increase in Alzheimer's Disease Risk

Neuronal ApoE4 in Alzheimer's disease and potential therapeutic targets

APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types

Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits

α-synuclein in the pathophysiology of Alzheimer’s disease

Single‐nuclei Spatiotemporal Transcriptomics Reveal an APOE4‐associated Specific Oligodendrocyte Signature

The influence of APOEε4 on the pTau interactome in sporadic Alzheimer's disease

APOE4/4 is linked to damaging lipid droplets in Alzheimer's disease microglia